Unlike traditional therapies, Avandia targets the underlying causes of type 2 diabetes – insulin resistance and associated beta-cell failure giving your type 2 diabetes patients sustained glycemic control, and more to feel good about

Sustained glycemic control/Years of benefits.

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.